Press Releases

Home / Investor Relations / Press Releases

Language

Category

Year

2022-01-17 08:41 Boule appoints Annette Colin as CFO

Boule Diagnostics AB appoints Annette Colin as its new CFO effective April 4th, 2022. Annette Colin brings more than 25 years of experience from executive positions such as CEO, CFO, COO, and Group Financial Controller, including 15+ years in the Life...

2021-12-09 16:31 CFO Christina Rubenhag will leave Boule in June, 2022 Regulatory

Boule Diagnostics AB’s CFO Christina Rubenhag has decided to leave her position and assume the position of CFO at AddLife. Christina has had her position since 2017 and will continue in this capacity during her six-month notice period in order to ensure...

2021-11-10 08:31 Boule Diagnostics (publ) Interim report July–September 2021 Regulatory

Continued growth for all products Quarter July-September 2021 CEO Jesper Söderqvist Continued recovery and well-filled order book We have seen a continued recovery in the market, and during the third quarter, the positive trend in both sales and order...

2021-11-02 15:01 Boule Diagnostics – Invitation to presentation of the interim report Q3 2021

Boule Diagnostics AB will publish the interim report for the period January–September 2021 at 08:30, Wednesday, November 10th, 2021. Following the publication, Boule will hold a Teams Live Event at 09:00 for media and investors. CEO Jesper Söderqvist...

2021-10-22 15:01 Boule Diagnostics – Nomination Committee for the 2022 Annual General Meeting

The Annual General Meeting, (”AGM”), 2021 of Boule Diagnostics AB (publ), (”Boule”), decided that a Nomination Committee based on the ownership structure as per September 30, 2021, will be appointed to propose for the AGM of 2022 the following...

2021-07-19 08:31 Boule Diagnostics (publ) Interim report April–June 2021 Regulatory

Strong improvement in instrument sales

2021-07-07 15:01 Boule Diagnostics – Invitation to presentation of the half-year report Q2 2021

Boule Diagnostics AB will publish the half-year report for the period January–June 2021 at 08:30, Monday, July 19th, 2021. Following the publication, Boule will hold a Teams Live Event at 10:00 for media and investors. CEO Jesper Söderqvist and...

2021-05-06 19:31 Bulletin from Annual General Meeting in Boule Diagnostics AB on May 6, 2021

Due to the continued spread of the coronavirus and with the purpose to reduce the risk of infection the Annual General Meeting was carried out by way of advance voting (postal voting), with no physical participation. The Annual General Meeting 2021 (the...

2021-05-06 15:01 Boule Diagnostics (publ) Interim report January – March 2021 Regulatory

Gradual recovery and strong order intake

2021-05-03 15:01 Boule Diagnostics – Presentation of the interim report Q1 2021

Boule Diagnostics AB will publish the interim report for the period January–March 2021 at 15:00, Thursday, May 6th, 2021. Following the publication, Boule will hold a Teams Live Event at 16:00 for media and investors.

2021-04-15 15:01 Boule Diagnostics publishes the annual report for 2020 Regulatory

Boule Diagnostics AB has published the full Swedish annual report for the fiscal year 2020 at www.boule.com. The annual report is available in Swedish below and printed copies of the Swedish version will be available to shareholders upon request by late...

2021-03-03 17:01 Nomination Committee’s proposal for election of Board members and auditor of Boule Diagnostics AB

The Nomination Committee of Boule Diagnostics AB has decided to propose to the Annual General Meeting 2021 (AGM) that the number of Board members shall be seven including the Chairman. The Nomination Committee proposes the re-election of Peter Ehrenheim...

2021-02-03 15:01 Boule Diagnostics AB (publ) Year-end report January–December 2020 Regulatory

Progress in development but the pandemic impact continued Significant events during the quarter Boule´s proprietary technology at the core of the company’s new platform, write-down of acquired laser technology The development of the next generation...

2021-02-01 15:01 Boule Diagnostics – Presentation of the year-end report 2020

Boule Diagnostics AB will publish the year-end report for the period January–December 2020 at 15:00, Wednesday, February 3rd, 2021. Following the publication, Boule will hold a Teams Live Event at 16:00 for media and investors. CEO Jesper Söderqvist...

2020-12-22 17:01 Boule´s proprietary technology at the core of the new platform. Intangible assets are written down by SEK 40 million. Regulatory

The development of the next generation product platform has now reached a defining milestone regarding design, specification and choice of core technology. During the development process, different solutions were evaluated, one of which included the acquisition...

2020-11-05 15:02 Boule Diagnostics AB (publ) Interim report January–September 2020 Regulatory

Strong operating profit despite ongoing pandemic Significant events during the quarter Boule strengthens innovation and product development and appoints CTO On September 1, 2020, Helena Börjesson assumed the newly created position of Chief Technology...

2020-11-03 15:01 Boule Diagnostics – Presentation of the interim report Q3 2020

Boule Diagnostics AB will publish the interim report for the period January–September 2020 at 15:00, Thursday, November 5th, 2020. Following the publication, Boule will hold a conference call at 16:00 for media and investors. CEO Jesper Söderqvist...

2020-10-22 15:01 Boule Diagnostics – Nomination Committee for the 2021 Annual General Meeting

The Annual General Meeting, (”AGM”), 2020 of Boule Diagnostics AB (publ), (”Boule”), decided that a Nomination Committee based on the ownership structure as per September 30, 2020, will be appointed to propose for the AGM of 2021 the following...

2020-08-31 08:31 Boule has signed a long-term supply agreement with one of the company’s major OEM clients

Boule Diagnostics AB has extended a longstanding partnership with a global leader in the diagnostics sector providing products and services for the hematology markets. The parties have signed a supply agreement with an initial term of 10 years, and potential...

2020-08-26 08:31 Boule strengthens innovation and product development and appoints Helena Börjesson as CTO

Boule Diagnostics appoints Helena Börjesson as Chief Technology Officer (CTO) as of September 1, 2020. Helena has been with Boule in an interim position as SVP R&D for hematology instruments since the spring of 2020 and has proved valuable in advancing...

Previous Next